¼¼°èÀÇ ¾ËųȭÁ¦ ½ÃÀå º¸°í¼­(2025³â)
Alkylating Agents Global Market Report 2025
»óǰÄÚµå : 1764237
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,292,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,095,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,897,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¾ËųȭÁ¦ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀÌ Àü¸ÁµË´Ï´Ù. 2029³â¿¡´Â CAGR 5.3%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 65¾ï 7,000¸¸ ´Þ·¯·Î ¼ºÀåÀÌ ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº ¾Ï ¿µ¿ªÀÇ ÆÄÀÌÇÁ¶óÀÎ È®´ë, °í·ÉÀÚ Áõ°¡, º´¿ë¿ä¹ý¿¡ ´ëÇÑ ¼ö¿ä °íÁ¶, ¸ÂÃãÇü ÀÇ·á ¼ºÀå, º¸Çè Àû¿ë È®´ë µî¿¡ ±âÀÎÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ ±â°£¿¡ ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ¾à¹° Àü´ÞÀÇ ±â¼úÀû ¹ßÀü, Áö¼ÓÀûÀÎ ¿¬±¸°³¹ß, Ç¥Àû¿ä¹ýÀÇ Çõ½Å, ½Å±Ô ¾ËųȭÁ¦ °³¹ß, Á¾¾çÇп¡¼­ÀÇ ÀΰøÁö´ÉÀÇ ÅëÇÕ µîÀÌ ÀÖ½À´Ï´Ù.

¾ÏÀÇ À¯º´·ü »ó½ÂÀº ÇâÈÄ ¼ö³â°£ ¾ËųȭÁ¦ ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¾ÏÀº °Ç°­ÇÑ Á¶Á÷¿¡ ħÀÔÇϰųª ÆÄ±«ÇÏ´Â ÀÌ»ó ¼¼Æ÷ÀÇ Á¦¾îÇÒ ¼ö ¾ø´Â Áõ½Ä ¹× È®»êÀ» Ư¡À¸·Î Çϸç, °ÅÀÇ ¸ðµç Àå±â³ª Á¶Á÷¿¡¼­ °³¹ßµÉ ¼ö ÀÖÀ¸¸ç, Ç÷¾×À̳ª ¸²ÇÁ°è¸¦ ÅëÇØ ÆÛÁý´Ï´Ù. ¾ÏÀÇ ÀÌȯÀ²ÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀº Àα¸ÀÇ °í·ÉÈ­°¡ ÁÖ¿ä ¿øÀÎÀÔ´Ï´Ù. À§Çè ÀÎÀÚ¿¡ Àå±â°£ ³ëÃâµÇ°í À¯ÀüÀû º¯À̰¡ Àå±â°£¿¡ °ÉÃÄ ÃàÀûµÇ¸é¼­ ¾Ï °³¹ß À§ÇèÀÌ ³ªÀ̰¡ µé¸é¼­ ÇöÀúÇÏ°Ô »ó½ÂÇϱ⠶§¹®ÀÔ´Ï´Ù. ¾ËųȭÁ¦´Â ¾Ï¼¼Æ÷ DNA¿¡ ¾Ëų±â¸¦ °áÇÕ½ÃÄÑ ¾ÏÀ» Ä¡·áÇÏ°í ¾Ï¼¼Æ÷ º¹Á¦´É·ÂÀ» ÆÄ±«ÇØ ¾Ï¼¼Æ÷¸¦ »ç¸ê½Ã۰í Á¾¾ç ¼ºÀåÀ» Áö¿¬½Ãŵ´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 10¿ù ¿µ±¹ ±¹¹Îº¸°Ç¼­ºñ½º(NHS)´Â 2022³â »õ·Ó°Ô 34¸¸ 6,217¸íÀÇ ¾Ï ȯÀÚ°¡ Áø´ÜµÅ ÇÏ·ç Æò±Õ 948¸íÀ̾ú´Ù°í º¸°íÇß½À´Ï´Ù. ±× °á°ú ¾Ï À¯º´·ü Áõ°¡°¡ ¾ËųȭÁ¦ ½ÃÀåÀÇ È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

¾ËųȭÁ¦ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº ´Ù¾çÇÑ °Ç°­ °ü¸® ȯ°æ¿¡¼­ ¿î¹Ý ¹× »ç¿ë ÆíÀǼºÀ» Çâ»ó½ÃŰ´Â ÁÖ»ç¿ë È­Çпä¹ýÁ¦¿Í °°Àº Çõ½ÅÀûÀÎ Á¦Ç° °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÁÖ»ç¿ë È­Çпä¹ýÁ¦´Â Á¤¸Æ ³» ¶Ç´Â Áֻ縦 ÅëÇØ Åõ¿©µÇ´Â ¾àÁ¦·Î, ¾Ï°ú ½Î¿ì´Â È­ÇÕ¹°À» Ç÷·ù ¶Ç´Â Á¶Á÷¿¡ Á÷Á¢ Àü´ÞÇÏ¿© ½Å¼ÓÇÑ Èí¼ö ¹× Ç¥Àû Á¾¾ç Ä¡·á¸¦ ½ÇÇöÇÕ´Ï´Ù. ¿¹¸¦ µé¸é, 2024³â 1¿ù, ¹Ì±¹ÀÇ Á¦¾à Á¦Á¶¾÷ü Avenacy Inc.´Â, È­ÇÐ ¿ä¹ý¿¡ »ç¿ëµÇ´Â ¾ËųȭÁ¦·Î ¾Ë·ÁÁø ¸áÆÄ¶õ¿°»ê¿°À» ¹ß¸ÅÇß½À´Ï´Ù. ÀÌ Á¦Ç°Àº µ¿°á°ÇÁ¶ ¸áÆÈ¶õ 50mg ¹ÙÀ̾˰ú ¸ê±ÕÈñ¼®¾× 10mL ¹ÙÀ̾˷Π½Ç¿Âº¸Á¸ÀÌ °¡´ÉÇϵµ·Ï ¹èÇյмö¼Û¼º°ú ÀÓ»ó Á¢±Ù¼ºÀ» ³ô¿´½À´Ï´Ù. ¶ÇÇÑ ¸áÆÄ¶õ¿°»ê¿°Àº Á¤È®ÇÑ ¾àÁ¦ ¼±ÅÃÀ» º¸ÀåÇϱâ À§ÇØ ÀÚü Æ÷Àå°ú ¶óº§À» äÅÃÇϰí ÀÖÀ¸¸ç, ¾ËÄ̶õ ÁÖ»ç¿ë°ú µ¿µîÇÑ Ä¡·á¿ë Á¦³×¸¯À¸·Î¼­ ƯÈ÷ °æ±¸ ¿ä¹ýÀÌ ºÎÀû´çÇÑ °æ¿ì ´Ù¹ß¼º °ñ¼öÁ¾ ȯÀÚÀÇ ¿ÏÈ­ Ä¡·á¿¡ ÀûÀÀÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ ¹× Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ªÀüÀï ¹× °ü¼¼, Äڷγª ¹× ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼® ¹× Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº° ¹× ±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ ¹× ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å· ¹× ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹® ¹× Àü·«

Á¦36Àå ºÎ·Ï

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Alkylating agents are a group of highly reactive chemical compounds that function by transferring alkyl groups (consisting of carbon and hydrogen atoms) to DNA molecules. This action disrupts the DNA's structure and function, ultimately hindering cell replication and causing cell death.

The primary types of alkylating agents include nitrogen mustards, nitrosoureas, aziridines, ethylenimines, triazines, and alkyl sulfonates. Nitrogen mustards are chemotherapy alkylating agents that interfere with cancer cell DNA replication by attaching alkyl groups, resulting in cell death. They can be administered via various routes, including oral and intravenous methods, and are applied in fields such as oncology and hematology. These agents are used by a range of end users, including hospitals, specialty clinics, homecare providers, and others.

The alkylating agents market research report is one of a series of new reports from The Business Research Company that provides alkylating agents market statistics, including the alkylating agents industry global market size, regional shares, competitors with the alkylating agents market share, detailed alkylating agents market segments, market trends, and opportunities, and any further data you may need to thrive in the alkylating agents industry. These alkylating agents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The alkylating agents market size has grown strongly in recent years. It will grow from $5.06 billion in 2024 to $5.34 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth during the historic period can be attributed to the early adoption of chemotherapy, increased healthcare spending, limited availability of alternative treatments, regulatory approvals, and the expansion of hospital infrastructure.

The alkylating agents market size is expected to see strong growth in the next few years. It will grow to $6.57 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to the expanding oncology pipeline, an increasing geriatric population, rising demand for combination therapies, growth in personalized medicine, and broader insurance coverage. Key trends expected during this period include technological advancements in drug delivery, continuous research and development, innovations in targeted therapies, the development of new alkylating compounds, and the integration of artificial intelligence in oncology.

The rising prevalence of cancer is expected to drive the growth of the alkylating agents market in the coming years. Cancer is characterized by the uncontrolled growth and spread of abnormal cells that can invade or destroy healthy tissue, potentially developing in nearly any organ or tissue and spreading through the blood and lymphatic systems. The increasing incidence of cancer is largely attributed to aging populations, as the risk of developing cancer rises significantly with age due to prolonged exposure to risk factors and the accumulation of genetic mutations over time. Alkylating agents treat cancer by attaching alkyl groups to the DNA of cancer cells, disrupting their ability to replicate, leading to cancer cell death and slowing tumor growth. For example, in October 2024, the National Health Service (NHS) of the UK reported that 346,217 new cancer cases were diagnosed in 2022, averaging 948 cases per day-a 5% increase from the 329,664 cases recorded in 2021. Consequently, the growing prevalence of cancer is fueling the expansion of the alkylating agents market.

Leading companies in the alkylating agents market are focusing on developing innovative products such as injectable chemotherapeutic agents that improve transportability and ease of use across various healthcare environments. Injectable chemotherapeutic agents are drugs administered intravenously or by injection, delivering cancer-fighting compounds directly into the bloodstream or tissues for rapid absorption and targeted tumor treatment. For example, in January 2024, Avenacy Inc., a US-based pharmaceutical manufacturer, launched Melphalan Hydrochloride, a well-known alkylating agent used in chemotherapy. This product comes as a 50 mg vial of lyophilized melphalan and a 10 mL vial of sterile diluent, formulated for room-temperature storage to enhance transportability and clinical accessibility. Melphalan Hydrochloride also features proprietary packaging and labeling to ensure accurate medication selection and serves as a therapeutic equivalent generic to Alkeran for Injection, specifically indicated for palliative treatment of multiple myeloma patients when oral therapy is unsuitable.

In June 2024, Dr. Reddy's Laboratories Limited, an India-based pharmaceutical company, partnered with Ingenus Pharmaceuticals, LLC, a US-based pharmaceutical firm, to commercialize Cyclophosphamide injection. Through this collaboration, both companies aim to enhance their presence in the US oncology market by increasing the availability of Cyclophosphamide injection for cancer treatment. Ingenus Pharmaceuticals LLC specializes in injectable and complex generic pharmaceutical products across critical therapeutic areas, including oncology.

Major players in the alkylating agents market are Pfizer Inc., Merck KGaA, AstraZeneca PLC, Novartis AG, Fresenius Kabi AG, Teva Pharmaceuticals USA Inc., Baxter Healthcare Corporation, Apotex Inc., Jiangsu Hengrui Pharmaceuticals Co. Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Limited, Aspen Pharmacare Holdings Limited, Zydus Lifesciences Limited, Emcure Pharmaceuticals Ltd., KRKA d. d. Novo mesto, Sagent Pharmaceuticals Inc., Debiopharm International SA, Accord Healthcare Ltd., NextSource Biotechnology LLC.

North America was the largest region in the alkylating agents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in alkylating agents report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the alkylating agents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The alkylating agents market consists of sales of aziridines, hydrazines, ethylenimines, methylmelamines and ifosfamide. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified.)

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Alkylating Agents Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on alkylating agents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for alkylating agents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The alkylating agents market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Alkylating Agents Market Characteristics

3. Alkylating Agents Market Trends And Strategies

4. Alkylating Agents Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Alkylating Agents Growth Analysis And Strategic Analysis Framework

6. Alkylating Agents Market Segmentation

7. Alkylating Agents Market Regional And Country Analysis

8. Asia-Pacific Alkylating Agents Market

9. China Alkylating Agents Market

10. India Alkylating Agents Market

11. Japan Alkylating Agents Market

12. Australia Alkylating Agents Market

13. Indonesia Alkylating Agents Market

14. South Korea Alkylating Agents Market

15. Western Europe Alkylating Agents Market

16. UK Alkylating Agents Market

17. Germany Alkylating Agents Market

18. France Alkylating Agents Market

19. Italy Alkylating Agents Market

20. Spain Alkylating Agents Market

21. Eastern Europe Alkylating Agents Market

22. Russia Alkylating Agents Market

23. North America Alkylating Agents Market

24. USA Alkylating Agents Market

25. Canada Alkylating Agents Market

26. South America Alkylating Agents Market

27. Brazil Alkylating Agents Market

28. Middle East Alkylating Agents Market

29. Africa Alkylating Agents Market

30. Alkylating Agents Market Competitive Landscape And Company Profiles

31. Alkylating Agents Market Other Major And Innovative Companies

32. Global Alkylating Agents Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Alkylating Agents Market

34. Recent Developments In The Alkylating Agents Market

35. Alkylating Agents Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â